More recently, we launched our Zuellig Health Solutions Innovation Centre to develop new services and address some pressing healthcare needs in Asia. Since then, our teams have been focused on creating data, digital and disease management solutions, supporting patients with chronic conditions and helping payors manage healthcare costs.
Overview
Mentions in press and media 16
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 12, 2025 | Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti® and Rexulti® driven by additional investments | VALBY, Denmark, Nov. 12, 2025 /PRNewswire/ -- Key highlights Lundbeck's total revenue grew by +14% CER[1] (+13% DKK) to DKK 18,537 million in the first nine months of 2025. Growth in the U.S. and Europe was the driver of this strong perform... |
| Nov 11, 2025 | Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti[®] and Rexulti[®] driven by additional investments | Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti[®] and Rexulti[®] driven by additional investments Tue, Nov 11, 2025 15:34 CET Report this content Key highlights Lundbeck’s total revenue grew by +14% CER[1... |
| Sep 9, 2025 | Lundbeck sharpens commercial focus in line with strategy, initiates partnering in 27 markets by end-2025 | Lundbeck sharpens commercial focus in line with strategy, initiates partnering in 27 markets by end-2025 Tue, Sep 09, 2025 14:30 CET Report this content Three new regional partnerships will secure continuity of today’s commercial activities... |
| Jul 8, 2025 | Zuellig Pharma Launches "Obesity is a Disease" Seminar as Part of "Reduce Size, Reduce Disease" Campaign | The campaign aims to enhance the understanding of obesity as a chronic disease and solutions to help manage the disease among Thais and healthcare providers. BANGKOK, July 8, 2025 /PRNewswire/ -- Zuellig Pharma, a leading healthcare solutio... |
| May 22, 2025 | Workato Appoints Will Corkery as Chief Revenue Officer Amid Global Enterprise Momentum | Workato, the leader in agentic orchestration, today announced the appointment of industry powerhouse Will Corkery as Chief Revenue Officer (CRO). His arrival comes amid unprecedented momentum for Workato—fueled by surging enterprise demand ... |
| Nov 11, 2024 | Economist Impact's 4th edition Future of Health Asia to empower healthcare stakeholders by building strategies for a sustainable healthcare system, and igniting investment for an inclusive and healthier future | Members of the media are invited to register here. SINGAPORE, Nov. 11, 2024 /PRNewswire/ -- The 4th edition Future of Health Asia today announced the confirmed speaker line-up for the 2024 event. Building on the success of three editions, F... |
| Mar 17, 2024 | Green Revolution: Meet Malaysia’s Top 11 Fertilizer Suppliers | Share Tweet Share Share Email The Green Revolution, a period of significant agricultural transformation that began in the mid-20th century, has been instrumental in increasing agricultural productivity worldwide. Central to this revolution ... |
| Sep 28, 2022 | A century of making healthcare more accessible in Asia | In the thick of the global COVID-19 pandemic, Zuellig Pharma worked closely with governments in Asia Pacific to make COVID-19 vaccines more accessible, leveraging digital technology and its wide distribution networks. Its ZP Therapeutics di... |
| Oct 5, 2021 | Zuellig Pharma Receives EcoVadis Platinum Medal in 2021 For Sustainability | SINGAPORE, Oct. 5, 2021 /PRNewswire/ -- Zuellig Pharma, a leading healthcare services provider in Asia, has been awarded the Platinum Medal 2021 by sustainability ratings specialist EcoVadis. The award is the highest accolade to be awarded ... |
Reviews 0
FAQ about Zuellig Pharma
When was Zuellig Pharma founded?
Zuellig Pharma was founded in 1922.
What has the press written about Zuellig Pharma?
Parsers VC has collected 16 articles mentioning Zuellig Pharma, among them “Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti® and Rexulti® driven by additional investments” (Nov 12, 2025) and “Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti[®] and Rexulti[®] driven by additional investments” (Nov 11, 2025).
Is Zuellig Pharma still active?
Yes, Zuellig Pharma is active; its latest activity on Parsers VC dates from Dec 2, 2025.